1
|
Zhu P, Yue M, Chen Q, Yao M, Wu JJ, Shao JG, Xue H, Zhang Y, Huang P, Wang CH. [Study of tumor necrosis factor receptor superfamily 1B gene polymorphism in relation to the outcomes of HCV infection]. Zhonghua Gan Zang Bing Za Zhi 2019; 27:793-798. [PMID: 31734995 DOI: 10.3760/cma.j.issn.1007-3418.2019.10.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the tumor necrosis factor receptor superfamily 1B gene (TNFRSF1B) polymorphism in relation to the outcomes of hepatitis C virus (HCV) infection. Methods: One thousand six hundred and forty-five cases without HCV infection, 545 cases with HCV clearance, and 783 cases with chronic HCV infection were enrolled. TaqMan probe method was used to investigate genotype rs1061622 (T > G) and rs1061624 (G > A). Two single nucleotide polymorphisms (SNPs) sites were genotyped and haplotypes were constructed to evaluate their relation with the outcome of HCV infection. Results: Logistic regression analysis showed that there was no relation to the two SNPs with HCV infection susceptibility and chronicity (P > 0.05). Haplotype analysis showed that carrier TA had an increased susceptibility to HCV infection [adjusted odds ratio (OR) = 1.15, 95% confidence interval (CI): 1.01 to 1.30, P = 0.038)]. Carrier TA and GG haplotypes were conducive to chronic HCV infection (adjusted OR = 1.28, 95% CI: 1.08 to 1.53, P = 0.006; OR = 1.31, 95% CI: 1.03 to 1.66, P = 0.026). Conclusion: The combinational effects of rs1061622 and rs1061624 in TNFRSF1B gene may increase the risk of HCV chronicity and infection.
Collapse
Affiliation(s)
- P Zhu
- Medical Department, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - M Yue
- Department of Infectious Diseases, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
| | - Q Chen
- Eastern Theater Command Centers for Disease Control and Prevention, Nanjing 210002, China
| | - M Yao
- Department of Immunology, Medical School of Nantong University, Nantong 226001, China
| | - J J Wu
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - J G Shao
- Department of Gastroenterology, the Nantong Third Affiliated Hospital of Nantong University, Nantong 226001, China
| | - H Xue
- Fourth Ward, the Nantong Third Affiliated Hospital of Nantong University, Nantong 226001, China
| | - Y Zhang
- Eastern Theater Command Centers for Disease Control and Prevention, Nanjing 210002, China; Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - P Huang
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing 211166, China
| | - C H Wang
- Eastern Theater Command Centers for Disease Control and Prevention, Nanjing 210002, China
| |
Collapse
|